CAS 1397922-61-0

Pyrotinib dimaleate

CAS : 1397922-61-0

Pyrotinib dimaleate is a selective EGFR/HER2 dual inhibitor, respectively, for the treatment of HER2-positive breast cancer.Cost-effective and quality-assured.

Formule : C₄₀H₃₉ClN₆O₁₁

Degré de pureté : 97.27% - 99.52%

Couleur et forme : Solid

Masse moléculaire : 815.22

Ref: TM-T12594

Pyrotinib dimaleate

CAS : 1397922-61-0

Pyrotinib dimaleate

Formule : C₄₀H₃₉ClN₆O₁₁

Degré de pureté : ≥95%

Masse moléculaire : 815.22

Ref: 54-BUP12739

Pyrotinib dimaleate

CAS : 1397922-61-0

Pyrotinib dimaleate is a potent antitumor agent that binds to the epidermal growth factor receptor (EGFR) and inhibits the proliferation of cancer cells. The molecular weight of pyrotinib dimaleate is 576.63 daltons, which is too large for intravenous administration. Pyrotinib dimaleate has been shown to inhibit the growth of solid tumours in animals, but no clinical trials have been conducted on humans. Experiments using a quinoline derivative with a smaller molecular weight are currently being conducted. In animal models, pyrotinib dimaleate has shown an effective dose between 10-30 mg/kg/day.

Formule : C₄₀H₃₉ClN₆O₁₁

Degré de pureté : Min. 95%

Masse moléculaire : 815.22 g/mol

Ref: 3D-XFC92261

Pyrotinib dimaleate

CAS : 1397922-61-0

Formule : C₄₀H₃₉ClN₆O₁₁

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 815.2243

Ref: IN-DA01EO88